In yesterday’s Wall Street session, Clover Health Investments Corp (NASDAQ:CLOV) shares traded at $1.01, up 10.89% from the previous session.
4 analysts cover Clover Health Investments Corp (NASDAQ:CLOV), according to research data. The consensus rating among analysts is ‘Hold’. As we calculate the median target price by taking the range between a high of $3.00 and a low of $1.50, we find $1.63. Given the previous closing price of $0.91, this indicates a potential upside of 79.12 percent. CLOV stock price is now -9.11% away from the 50-day moving average and -3.63% away from the 200-day moving average. The market capitalization of the company currently stands at $489.71M.
The stock has received a hold rating from 3 analysts and a buy rating from 1. Brokers who have rated the stock have averaged $1.94 as their price target over the next twelve months.
With the price target reduced from $7 to $3, Cowen Upgraded its rating from Underperform to Market Perform for Clover Health Investments Corp (NASDAQ: CLOV).
In other news, Loengard Anna U, Director bought 11,000 shares of the company’s stock on Sep 06. The stock was bought for $14,300 at an average price of $1.30. Upon completion of the transaction, the Director now directly owns 10,000 shares in the company, valued at $10100.0. Insiders disposed of 1,675,895 shares of company stock worth roughly $1.69 million over the past 1 year. A total of 23.57% of the company’s stock is owned by insiders.
On Thursday morning Clover Health Investments Corp (NASDAQ: CLOV) stock kicked off with the opening price of $0.9300. During the past 12 months, Clover Health Investments Corp has had a low of $0.71 and a high of $1.63. The fifty day moving average price for CLOV is $1.1054 and a two-hundred day moving average price translates $1.0470 for the stock.
The latest earnings results from Clover Health Investments Corp (NASDAQ: CLOV) was released for Jun, 2023. According to the Healthcare Plans Company, earnings per share came in at -$0.06, beating analysts’ expectations of -$0.15 by 0.09. This compares to -$0.22 EPS in the same period last year. The net profit margin was -9.33% and return on equity was -68.85% for CLOV. The company reported revenue of $513.63 million for the quarter, compared to $846.7 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue fell -39.34 percent. For the current quarter, analysts expect CLOV to generate $494.6M in revenue.
Clover Health Investments Corp(CLOV) Company Profile
Clover Health Investments, Corp. provides medicare advantage plans in the United States. The company through its Clover Assistant, a software platform that provides preferred provider organization and health maintenance organization health plans for medicare-eligible consumers. It also focuses on non-insurance businesses. The company was incorporated in 2014 and is based in Franklin, Tennessee.
